schedule of pharmaceutical benefits for approved pharmacists and medical practitioners operative

529 Pages·2004·5.8 MB·English

by  Brian Carr

SCHEDULE OF PHARMACEUTICAL
BENEFITS FOR APPROVED
PHARMACISTS AND MEDICAL
PRACTITIONERS

OPERATIVE FROM 1 DECEMBER 2004
(ALL PREVIOUS EDITIONS CANCELLED)
2
© Commonwealth of Australia 2004
ISSN 1037-3667

This work is copyright. Apart from any use as permitted under the Copyright Act 1968, no part
may be reproduced by any process without written permission from the Commonwealth available
from Information Services. Requests and inquiries concerning reproduction and rights should be
addressed to the Manager, Copyright Services, Information Services, GPO Box 1920, Canberra
ACT 2601 or by e-mail [email protected].

This Schedule provides information on the arrangements for the prescribing of
pharmaceutical benefits by medical practitioners and participating dental practitioners,
and the supply of pharmaceutical benefits by approved pharmacists, approved medical
practitioners and approved hospital authorities. These arrangements operate under the
National Health Act 1953. However, at the time of printing, the relevant legislation
giving authority for the changes included in this issue of the Schedule may still be
subject to the usual Parliamentary scrutiny. This book is not a legal document, and, in
cases of discrepancy, the legislation will be the source document for payment for the
supply of pharmaceutical benefits.
3
CONTENTS

Page Page
SUMMARY OF CHANGES..............................................5 Repeat authorisations for injectables and
ADDRESSES — HEALTH INSURANCE solvents.......................................................35
COMMISSION..........................................................13 Repeat authorisations for deferred supply........35
AUTHORITY PRESCRIPTION APPLICATIONS...........14 Authority prescriptions.............................................36
REQUESTS FOR DRUGS VIA THE SPECIAL Urgent cases............................................................36
ACCESS SCHEME (SAS).......................................14 Receipts...................................................................36
POISONS INFORMATION CENTRES...........................15 Emergency drug (doctor's bag) supplies.................36
DRUG INFORMATION CENTRES.................................15
LIST OF CONTACT OFFICERS FOR RECALLS OF 4. PATIENT CHARGES...............................................37
THERAPEUTIC GOODS..........................................16 Type of patient.........................................................37
INDEX OF MANUFACTURERS' CODES......................17 Establishing entitlement...........................................37
What to charge.........................................................37
Patient contribution............................................37
SECTION 1 — EXPLANATORY NOTES — Special patient contributions, brand premiums
YELLOW PAGES and therapeutic group premiums................38
Solvents.............................................................38
INTRODUCTION............................................................27 Increased quantities..........................................38
Regulation 24....................................................38
1. THE SCHEDULE — WHERE TO FIND WHAT........27 After hours.........................................................38
Section 1 (yellow pages)..........................................27 Delivery..............................................................39
Section 2 (white, pink and orange pages)................27
Section 3 (blue pages)..............................................28 5. THE SAFETY NET SCHEME..................................39
Section 4 (green pages)...........................................28 Safety net thresholds...............................................39
Repatriation Schedule of Pharmaceutical Benefits..28 Safety net cross-over arrangements.................39
Recording prescriptions...........................................40
2. PRESCRIBING MEDICINES — INFORMATION Hospital PRF's.........................................................41
FOR DOCTORS AND DENTISTS............................28 Multi-item forms.......................................................41
Eligible prescribers...................................................28 Qualifying prescriptions............................................41
Prescription forms.....................................................28 Lost PRF's...............................................................41
Ordering forms...................................................29 Retrospective entitlement and patient refunds........41
Preparing general prescriptions................................29 Applying for a Safety Net Entitlement/Concession
Do's and don't's..................................................29 Card...................................................................42
Writing the prescription......................................30 Issuing a Safety Net Entitlement/Concession Card.42
Restrictions...............................................................30 Issuing supplementary cards...................................42
Authority prescriptions..............................................30 Notification to HIC and claim for payment...............42
Writing authority prescriptions............................31 Lost Safety Net Entitlement/Concession Cards.......42
Maximum quantities and repeats..............................31 Pharmacy record of issued cards............................43
Regulation 24...........................................................32 6. HIC ENTITLEMENT CHECKS.................................43
Urgent cases............................................................32 General..............................................................43
Drugs of addiction.....................................................32 Concessional.....................................................43
Emergency drug (doctor's bag) supplies..................32 Entitlement checking procedures.............................43
General..............................................................43
3. SUPPLYING MEDICINES — WHAT Concessional.....................................................43
PHARMACISTS NEED TO KNOW..........................33 Step by step.......................................................44
Eligible suppliers.......................................................33
Approval conditions for pharmacists..................33 7. HOW PHARMACISTS CLAIM REIMBURSEMENT:
Before supplying pharmaceutical benefits................33 INFORMATION REQUIRED....................................44
Supplying pharmaceutical benefits...........................34 Prescription identification.........................................44
Do's and don't's..................................................34 Serial numbers.........................................................45
What to do if the Schedule changes..................34 Repeat authorisations for authority
Suspected forgery....................................................35 prescriptions...............................................45
Regulation 24...........................................................35 Repeat authorisations for deferred supply........45
Repeat authorisations...............................................35 Injectable item ordered with a solvent...............45
Preparing repeat authorisation forms.................35
4
Page Page
Dropper containers..................................................46 SECTION 2 — READY-PREPARED
Extemporaneously-prepared pharmaceutical PHARMACEUTICAL BENEFITS —
benefits not included in the Standard Formulae WHITE, BLUE, PINK AND ORANGE PAGES........61
List ....................................................................46 Symbols...................................................................62
Prescriptions paid on an average price basis...46 Emergency Drug (Doctor's Bag) Supplies...............65
Pricing non-pre-priced extemporaneous Special Pharmaceutical Benefits.............................68
preparations................................................46 General Pharmaceutical Benefits ...........................69
RPBS prescriptions for items not included in either Pharmaceutical Benefits for Palliative Care ..........297
the PBS or RPBS Schedule..............................46 Pharmaceutical Benefits for Dental Use................305
Items Available under Special Arrangements
8. HOW PHARMACISTS CLAIM REIMBURSEMENT: (section 100)....................................................331
DOCUMENTS TO BE SUBMITTED........................46
Completing the claim form.......................................47 SECTION 3 — STANDARD PACKS AND PRICES —
Lodging claims.........................................................47 BLUE PAGES........................................................391
Statement of account...............................................47 Container Prices and Fees for Ready Prepared
Pharmaceutical Benefits..................................391
9. PRICING PRESCRIPTIONS...................................48 Standard Packs and Prices for Ready Prepared
Pricing principles......................................................48 Pharmaceutical Benefits..................................392
Pricing dates............................................................48
Pricing ready-prepared items...................................48 SECTION 4 — EXTEMPORANEOUSLY-PREPARED
For maximum quantities....................................48 PHARMACEUTICAL BENEFITS —
For lesser quantities..........................................48 GREEN PAGES.....................................................403
Wastage table percentage.......................................49 Drug Tariff..............................................................404
Pricing extemporaneously-prepared items..............49 Container Prices....................................................408
General..............................................................49 Standard Formula Preparations.............................409
Pricing of ingredients.........................................50 Table of Codes, Maximum Quantities and Number
Pricing prescriptions where extra ingredients of Repeats for Extemporaneously Prepared
are added to a formula................................50 Pharmaceutical Benefits..................................411
Containers.........................................................50
Special provisions for extemporaneous REPATRIATION PHARMACEUTICAL BENEFITS —
Preparations outside the Standard WHITE, MAUVE AND BUFF PAGES...................413
Formulae List..............................................50 Beneficiaries' Entitlement Cards............................414
Explanatory Notes..................................................416
10. MISCELLANEOUS..................................................51 Summary of Changes............................................421
References..............................................................51 Therapeutic Index..................................................423
Standards ...............................................................51 SECTION 1 — Drugs, Medicines and Dressings...427
Legislation................................................................51 SECTION 2 — Standard Packs and Prices...........467

THERAPEUTIC INDEX — MAUVE PAGES.................53 GENERIC/PROPRIETARY INDEX —
MAUVE PAGES....................................................471
5
PHARMACEUTICAL BENEFITS
This Schedule will take effect on 1 December 2004 and all previous issues are cancelled.
New Schedules will take effect on 1 April, 1 August and 1 December each year.

Change of Address

Notification of change of address should be directed to the Pharmaceutical Branch, Health
Insurance Commission, GPO Box 9826, in your Capital City, or telephone 132 290.

Internet

The Schedule of Pharmaceutical Benefits is also available on the Department of Health and
Ageing’s internet site at www.health.gov.au.
The address of the Schedule is http://www1.health.gov.au/pbs/index.htm.

Fees, Patient Contributions and Safety Net Thresholds

The following fees, patient contributions and safety net thresholds apply as at 1 December 2004
and are included, where applicable, in prices published in the Schedule—

Dispensing Fees: Ready-prepared $4.70
Dangerous drug fee $2.61
Extemporaneously-prepared $6.70

Additional Fees (for safety net prices): Ready-prepared $0.95
Extemporaneously-prepared $1.35

Patient Co-payments: General $23.70
Concessional $3.80

Safety Net Thresholds: General $726.80
Concessional $197.60

Safety Net Card Issue Fee: $7.05

Patient Contributions and Safety Net Thresholds from 1 January 2005

The following patient contributions and safety net thresholds will apply from 1 January 2005—

Patient Co-payments: General $28.60
Concessional $4.60

Safety Net Thresholds: General $874.90
Concessional $239.20
6
SUMMARY OF CHANGES
ADDITIONS
Additions — Items

8773R Anakinra, injection 100 mg in 0.67 mL single use pre-filled syringe (Kineret)
8774T Anakinra, injection 100 mg in 0.67 mL single use pre-filled syringe (Kineret)
(Diff. Max. Rpts)
8760C Captopril, oral solution 5 mg per mL, 95 mL (Capoten)
8775W Fondaparinux Sodium, injection 2.5 mg in 0.5 mL single dose pre-filled syringe (Arixtra)
8770N Galantamine Hydrobromide, capsule 8 mg (base) (prolonged release) (Reminyl)
8771P Galantamine Hydrobromide, capsule 16 mg (base) (prolonged release) (Reminyl)
8772Q Galantamine Hydrobromide, capsule 24 mg (base) (prolonged release) (Reminyl)
8769M Gefitinib, tablet 250 mg (Iressa)
8766J Glucose Indicator—Blood, electrode strips, 50 (GlucoCare Super Sensor)
8759B Glucose Indicator—Blood, reagent strips, 50 (CareSens)
8768L Mesalazine, rectal foam 1 g per applicatorful, 14 applications, aerosol 80 g (Salofalk)
8761D Oestradiol, transdermal patches 390 micrograms (releasing approximately
25 micrograms per 24 hours), 8 (Estradot 25)
8762E Oestradiol, transdermal patches 585 micrograms (releasing approximately
37.5 micrograms per 24 hours), 8 (Estradot 37.5)
8763F Oestradiol, transdermal patches 780 micrograms (releasing approximately
50 micrograms per 24 hours), 8 (Estradot 50)
8764G Oestradiol, transdermal patches 1.17 mg (releasing approximately 75 micrograms
per 24 hours), 8 (Estradot 75)
8765H Oestradiol, transdermal patches 1.56 mg (releasing approximately 100 micrograms
per 24 hours), 8 (Estradot 100)
8776X Omeprazole, tablet 20 mg (Meprazol)
8777Y Omeprazole, tablet 20 mg (Meprazol) (Diff. Max. Rpts)
8767K Sodium Cromoglycate, oral pressurised inhalation 1 mg per dose (200 doses), CFC-free
formulation (Intal CFC-Free)
8758Y Trandolapril, capsule 4 mg (Gopten)

Additions — Brands

2390T Ibimicyn, DP — Ampicillin, injection 500 mg (solvent required)
3313J Ibimicyn, DP — Ampicillin, injection 500 mg (solvent required) (Dental)
2977Q Ibimicyn, DP — Ampicillin, injection 1 g (solvent required)
3314K Ibimicyn, DP — Ampicillin, injection 1 g (solvent required) (Dental)
8318T Chem mart Clarithromycin, CH; Clarac, DP; GenRx Clarithromycin, GX; Kalixocin, AF;
Terry White Chemists Clarithromycin, TW— Clarithromycin, tablet 250 mg
1211R Fermil, AW — Clomiphene Citrate, tablet 50 mg
8019C GenRx Cyproterone Acetate, GX; Procur 100, DP — Cyproterone Acetate, tablet 100 mg
1834M Gabahexal 300mg, HX — Gabapentin, capsule 300 mg
1835N Gabahexal 400mg, HX — Gabapentin, capsule 400 mg
2449X Mellihexal, HX — Gliclazide, tablet 80 mg
2848X Elmendos, ME — Lamotrigine, tablet 25 mg
2849Y Elmendos, ME — Lamotrigine, tablet 50 mg
2850B Elmendos, ME — Lamotrigine, tablet 100 mg
2851C Elmendos, ME — Lamotrigine, tablet 200 mg
8561N Movalis 7.5, AW — Meloxicam, tablet 7.5 mg
8562P Movalis 15, AW — Meloxicam, tablet 15 mg
7
2000G Butamol 2.5, AW — Salbutamol Sulfate, nebuliser solution single dose units
2.5 mg (base) in 2.5 mL, 30
3496B Butamol 2.5, AW — Salbutamol Sulfate, nebuliser solution single dose units
2.5 mg (base) in 2.5 mL, 30 (Doctor’s Bag)
2001H Butamol 5, AW — Salbutamol Sulfate, nebuliser solution single dose units 5 mg (base)
in 2.5 mL, 30
3497C Butamol 5, AW — Salbutamol Sulfate, nebuliser solution single dose units 5 mg (base)
in 2.5 mL, 30 (Doctor’s Bag)
2236Q Xydep 50, AW — Sertraline Hydrochloride, tablet 50 mg (base)
2237R Xydep 100, AW — Sertraline Hydrochloride, tablet 100 mg (base)
2011W Simvar 10, AW — Simvastatin, tablet 10 mg (effective 1 November 2004)
2012X Simvar 20, AW — Simvastatin, tablet 20 mg (effective 1 November 2004)
8173E Simvar 40, AW — Simvastatin, tablet 40 mg (effective 1 November 2004)
8313M Simvar 80, AW — Simvastatin, tablet 80 mg (effective 1 November 2004)
8455B Chem mart Tramadol, CH; GenRx Tramadol, GX; Terry White Chemists Tramadol, TW —
Tramadol Hydrochloride, capsule 50 mg
8611F Chem mart Tramadol, CH; GenRx Tramadol, GX; Terry White Chemists Tramadol, TW —
Tramadol Hydrochloride, capsule 50 mg (Diff. Max. Rpts)
5232J Chem mart Tramadol, CH; GenRx Tramadol, GX; Terry White Chemists Tramadol, TW —
Tramadol Hydrochloride, capsule 50 mg (Dental)
8280T MX — Vinorelbine Tartrate, solution for I.V. infusion 10 mg (base) in 1 mL
8281W MX — Vinorelbine Tartrate, solution for I.V. infusion 50 mg (base) in 5 mL

RETENTION OF BRANDS

Contrary to previous advice, the following brands will continue to be available as pharmaceutical
benefits from 1 December 2004:

1285P Danocrine, SW — Danazol, capsule 100 mg
1287R Danocrine, SW — Danazol, capsule 200 mg

BIOEQUIVALENCE INDICATORS

The bioequivalence indicator (a) has been added to the following brands:

2390T Austrapen, CS — Ampicillin, injection 500 mg (solvent required)
3313J Austrapen, CS — Ampicillin, injection 500 mg (solvent required) (Dental)
8318T Klacid, AB — Clarithromycin, tablet 250 mg
2848X Lamictal, GK — Lamotrigine, tablet 25 mg
2849Y Lamictal, GK — Lamotrigine, tablet 50 mg
2850B Lamictal, GK — Lamotrigine, tablet 100 mg
2851C Lamictal, GK — Lamotrigine, tablet 200 mg
8561N Mobic, BY — Meloxicam, tablet 7.5 mg
8562P Mobic, BY — Meloxicam, tablet 15 mg
2236Q Zoloft, PF — Sertraline Hydrochloride, tablet 50 mg (base)
2237R Zoloft, PF — Sertraline Hydrochloride, tablet 100 mg (base)
2011W Lipex 10, AD; Zocor, MK — Simvastatin, tablet 10 mg (effective 1 November 2004)
2012X Lipex 20, AD; Zocor, MK — Simvastatin, tablet 20 mg (effective 1 November 2004)
8173E Lipex 40, AD; Zocor, MK — Simvastatin, tablet 40 mg (effective 1 November 2004)
8313M Lipex 80, AD; Zocor, MK — Simvastatin, tablet 80 mg (effective 1 November 2004)
8280T Navelbine, FB — Vinorelbine Tartrate, solution for I.V. infusion 10 mg (base) in 1 mL
8281W Navelbine, FB — Vinorelbine Tartrate, solution for I.V. infusion 50 mg (base) in 5 mL
8
DELETIONS
Deletions — Items

1032H Aluminium Hydroxide with Magnesium Trisilicate and Magnesium Hydroxide,
tablet 250 mg-120 mg-120 mg (Gastrogel)
1044Y Ammonium Chloride, tablet 500 mg
1106F Bendrofluazide, tablet 5 mg (Aprinox)
8033T Cytarabine, injection 100 mg in 1 mL
8436B Follitropin Beta, solution for injection 50 i.u. in 0.5 mL (Puregon 50 IU/0.5 mL)
8279R Ipratropium Bromide, oral pressurised inhalation in breath actuated device
20 micrograms (anhydrous) per dose (200 doses) (Atrovent Autohaler)
8376W Omeprazole Magnesium and Clarithromycin and Amoxycillin, pack containing 14
tablets omeprazole 20 mg (base), 14 tablets clarithromycin 500 mg and 28 capsules
amoxycillin 500 mg (Losec Hp7)
8471W Rofecoxib, tablet 12.5 mg (Vioxx)
8472X Rofecoxib, tablet 25 mg (Vioxx)
8473Y Rofecoxib, oral suspension 12.5 mg per 5 mL, 150 mL (Vioxx)
8474B Rofecoxib, oral suspension 25 mg per 5 mL, 150 mL (Vioxx)
1100X Sodium Nitroprusside, I.V. infusion 50 mg
2664F Timolol Maleate with Pilocarpine Hydrochloride, eye drops 5 mg (base)-20 mg per mL
(0.5%-2%), 5 mL (Timpilo 2)
2665G Timolol Maleate with Pilocarpine Hydrochloride, eye drops 5 mg (base)-40 mg per mL
(0.5%-4%), 5 mL (Timpilo 4)

Deletions — Brands

3109P Midamor, MK — Amiloride Hydrochloride, tablet 5 mg
1784X Ceftriaxone-BC, BG — Ceftriaxone, injection 1 g (solvent required)
1785Y Ceftriaxone-BC, BG — Ceftriaxone, injection 2 g (solvent required)
1256D Cefazolin-BC, BG — Cephazolin, injection 500 mg (solvent required)
3161J Chem mart Diazepam, CH; GenRx Diazepam, GX; Terry White Chemists Diazepam, TW —
Diazepam, tablet 2 mg
5071X Chem mart Diazepam, CH; GenRx Diazepam, GX; Terry White Chemists Diazepam, TW —
Diazepam, tablet 2 mg (Dental)
3162K Chem mart Diazepam, CH; GenRx Diazepam, GX; Terry White Chemists Diazepam, TW —
Diazepam, tablet 5 mg
5072Y Chem mart Diazepam, CH; GenRx Diazepam, GX; Terry White Chemists Diazepam, TW —
Diazepam, tablet 5 mg (Dental)
1340M MX — Doxorubicin Hydrochloride, solution for I.V. injection or intravesical
administration 20 mg in 10 mL
2707L Chem mart Doxycycline, CH; GenRx Doxycycline, GX; healthsense Doxycycline, HS; Terry
White Chemists Doxycycline, TW — Doxycycline, capsule 50 mg
2708M Chem mart Doxycycline, CH; GenRx Doxycycline, GX; healthsense Doxycycline, HS; Terry
White Chemists Doxycycline, TW — Doxycycline, capsule 100 mg
2715X Chem mart Doxycycline, CH; GenRx Doxycycline, GX; healthsense Doxycycline, HS; Terry
White Chemists Doxycycline, TW — Doxycycline, capsule 100 mg (Max. Qty 21)
2703G Chem mart Doxycycline, CH; GenRx Doxycycline, GX; healthsense Doxycycline, HS; Terry
White Chemists Doxycycline, TW — Doxycycline, capsule 100 mg (Max. Qty 28)
3322W Chem mart Doxycycline, CH; GenRx Doxycycline, GX; healthsense Doxycycline, HS; Terry
White Chemists Doxycycline, TW — Doxycycline, capsule 100 mg (Dental)
1370D Enalapril-BC, BG — Enalapril Maleate, tablet 5 mg
1368B Enalapril-BC, BG — Enalapril Maleate, tablet 10 mg
9
1369C Enalapril-BC, BG — Enalapril Maleate, tablet 20 mg
2361G Agon SR, TP — Felodipine, tablet 2.5 mg (extended release)
2366M Agon SR, TP — Felodipine, tablet 5 mg (extended release)
2367N Agon SR, TP — Felodipine, tablet 10 mg (extended release)
2591J Accure 10, AF — Isotretinoin, capsule 10 mg
2592K Accure 20, AF — Isotretinoin, capsule 20 mg
1801T Metformin-BC, BG — Metformin Hydrochloride, tablet 850 mg
3037W Minomycin, SI — Minocycline, capsule 100 mg
2951H Trimoxazole-BC 800/160, BG — Trimethoprim with Sulfamethoxazole,
tablet 160 mg-800 mg
3390K Trimoxazole-BC 800/160, BG — Trimethoprim with Sulfamethoxazole,
tablet 160 mg-800 mg (Dental)

ALTERATIONS
Restriction Changes

8737W Adalimumab, injection 40 mg in 0.8 mL pre-filled syringe (Humira)
8741C Adalimumab, injection 40 mg in 0.8 mL pre-filled syringe (Humira) (Diff. Max. Rpts)
8179L Anastrazole, tablet 1 mg (Arimidex)
8637N Etanercept, injection set containing 4 vials powder for injection 25 mg and 4 pre-filled
syringes solvent 1 mL (Enbrel)
8638P Etanercept, injection set containing 4 vials powder for injection 25 mg and 4 pre-filled
syringes solvent 1 mL (Enbrel) (Diff. Max. Rpts)
8414W Irinotecan Hydrochloride Trihydrate, I.V. injection 40 mg in 2 mL (Camptosar)
8415X Irinotecan Hydrochloride Trihydrate, I.V. injection 100 mg in 5 mL (Camptosar)
2804N Terbinafine Hydrochloride, tablet 250 mg (base) (Lamisil)
1251W Terbutaline Sulfate, nebuliser solution single dose units 5 mg in 2 mL, 30 (Bricanyl
Respules)

Alterations — Notes

Notes have been added in respect of the following:

Adalimumab
Etanercept
Irinotecan Hydrochloride Trihydrate
Nandrolone Decanoate

Notes have been deleted in respect of the following:

Candesartan Cilexetil with Hydrochlorothiazide
Enalapril Maleate with Hydrochlorothiazide
Eprosartan Mesylate with Hydrochlorothiazide
Fosinopril Sodium with Hydrochlorothiazide
Irbesartan with Hydrochlorothiazide
Perindopril Erbumine with Indapamide Hemihydrate
Quinapril Hydrochloride with Hydrochlorothiazide
Telmisartan with Hydrochlorothiazide
10
Alterations — Manufacturer’s Code
From To
8054X Methylprednisolone Aceponate, cream 1 mg per g (0.1%), 15 g (Advantan) CS SC
8055Y Methylprednisolone Aceponate, ointment 1 mg per g (0.1%), 15 g CS SC
(Advantan)
8128T Methylprednisolone Aceponate, fatty ointment 1 mg per g (0.1%), 15 g CS SC
(Advantan)
8618N Methylprednisolone Aceponate, lotion 1 mg per g (0.1%), 20 g (Advantan) CS SC
2791X Trandolapril, capsule 500 micrograms (Odrik) AV KN
2792Y Trandolapril, capsule 1 mg (Odrik) AV KN
2793B Trandolapril, capsule 2 mg (Odrik) AV KN

SECTION 100 — HIGHLY SPECIALISED DRUGS PROGRAM
ADDITIONS
Additions — Items

6450L Adefovir Dipivoxil, tablet 10 mg (Hepsera)
6451M Atazanavir Sulfate, capsule 150 mg (base) (Reyataz)
6452N Atazanavir Sulfate, capsule 200 mg (base) (Reyataz)
6455R Enfuvirtide, pack containing 60 vials powder for injection 90 mg with 60 vials water for
injections 1.1 mL (with syringes and swabs) (Fuzeon)
6453P Fosamprenavir Calcium, tablet 700 mg (base) (Telzir)
6454Q Fosamprenavir Calcium, oral liquid 50 mg (base) per mL, 225 mL (Telzir)
6439X Peginterferon Alfa-2a, injection 135 micrograms in 0.5 mL single use pre-filled syringe
(Pegasys)
6449K Peginterferon Alfa-2a, injection 180 micrograms in 0.5 mL single use pre-filled syringe
(Pegasys)
DELETIONS
Deletions — Items

6346B Peginterferon Alfa-2b, powder for injection 50 micrograms vial with diluent ampoule
(PEG-Intron)
6347C Peginterferon Alfa-2b, powder for injection 80 micrograms vial with diluent ampoule
(PEG-Intron)
6348D Peginterferon Alfa-2b, powder for injection 100 micrograms vial with diluent ampoule
(PEG-Intron)
6349E Peginterferon Alfa-2b, powder for injection 120 micrograms vial with diluent ampoule
(PEG-Intron)
6350F Peginterferon Alfa-2b, powder for injection 150 micrograms vial with diluent ampoule
(PEG-Intron)

ALTERATIONS
Restriction Changes

6397Q Infliximab, powder for I.V. infusion 100 mg (Remicade)
6411K Peginterferon Alfa-2b, powder for injection 50 micrograms with diluent in single use
injection pen (PEG-Intron Redipen)
6412L Peginterferon Alfa-2b, powder for injection 80 micrograms with diluent in single use
injection pen (PEG-Intron Redipen)